Jazz seeks Priority Review from FDA and announces results from Dublin.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Jazz Pharmaceuticals →

  Irish tax-registered pharmaceutical corporation

  • Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
  • Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55
• Dublin →

  capital and largest city of Ireland

  • Managed waste services are currently being handled for the city of Dublin.Mon 15:35
  • Pilot studies are testing compostable aprons in Dublin, Donegal, and Cork.Mon 15:35

Related events

• Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.Aug 31
• Litigation regarding FDA approval process.Sep 2
• The FDA is reviewing drug data and company resubmissions, while also overseeing the functions of the U.S. Department of Health and Human Services.Aug 14
• GSK is seeking priority review for its Jemperli application, and the FDA set the PDUFA action date.Aug 25
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17